Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/TECH
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BIO-TECHNE Corp (TECH) Stock Price Today

OverviewTechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Bio-Techne (TECH) trades at $70.61, down 0.3% on the day, near its $73.00 takeover offer from Merck KGaA announced June 25, 2026. The stock shows bullish technical signals with strong moving averages, though RSI levels indicate overbought conditions. Fundamentals reveal a high P/E of 101.29 and declining net margins, but revenue remains stable near $1.22 billion. Cash flow improved in 2025 with $10.40M net inflow, and the balance sheet holds $152.86M cash against $319M long-term debt.
Outlook is dominated by the pending acquisition, offering a clear exit at $73.00, a 3.4% premium to current price. Risks include shareholder litigation questioning deal fairness and margin pressures. Analysts are unanimously positive with no sell ratings, seeing limited downside given the buyout bid. The stock presents a low-risk opportunity if the deal closes, but investors face uncertainty from legal challenges and earnings volatility.
Read full analysis

Key Stats

  • MARKET_CAP
    $11.00B
  • VOLUME
    -
  • SECTOR
    Health
  • FIFTY_TWO_WEEK_HIGH
    $71.38
  • FIFTY_TWO_WEEK_LOW
    $43.31
  • TYPICAL_HOLD_TIME
    -
  • ENTERPRISE_VALUE
    $11.08B
  • DIVIDEND_YIELD
    0.45%
  • TRADING_ACTIVITY
    -
$70.89
52W Low: $43.31
15 May 2026
52W High: $71.38
21 Jan 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $71.38, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Most Recent News

Content is generated by Aura AI

Global golf simulators market to reach $5.5B by 2035 with 8.6% CAGR, driven by tech advances and rising home use

The global golf simulators market, valued at $2.4 billion in 2025, is projected to grow to $5.5 billion by 2035 at an 8.6% CAGR. Growth is fueled by technological improvements, increased commercial and residential use, and rising demand for indoor go...

Market News
1 hour ago
Custom Market Insights
Bullish
news icon
pluang ai news

Capital Power signs 10+ year deal to supply 250 MW to Meta's Alberta data centre by 2028

Capital Power Corporation has entered a long-term energy supply agreement to provide 250 megawatts of power to Meta's new data centre in Sturgeon County, Alberta, expected to be operational in late 2028. This deal strengthens Capital Power's position...

Market News
2 hours ago
Na
Bullish
news icon
pluang ai news

Class action lawsuit filed over Megan Holdings' alleged misleading IPO disclosures causing investor losses.

A securities class action lawsuit has been filed against Megan Holdings Limited by investors who purchased shares during its September 2025 IPO or between September 2025 and May 2026. The lawsuit alleges the company made false and misleading statemen...

Market News
2 hours ago
Bernstein Liebhard Llp
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

Key Stats

  • MARKET_CAP
    $11.00B
  • VOLUME
    -
  • SECTOR
    Health
  • FIFTY_TWO_WEEK_HIGH
    $71.38
  • FIFTY_TWO_WEEK_LOW
    $43.31
  • TYPICAL_HOLD_TIME
    -
  • ENTERPRISE_VALUE
    $11.08B
  • DIVIDEND_YIELD
    0.45%
  • TRADING_ACTIVITY
    -
$70.89
52W Low: $43.31
15 May 2026
52W High: $71.38
21 Jan 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $71.38, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!